SPRB ONGOING INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 06/03/24
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024Business Wire • 06/03/24
IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 06/02/24
IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 06/01/24
IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 05/31/24
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 05/30/24
Spruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceBusiness Wire • 05/23/24
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine SocietyBusiness Wire • 05/22/24
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 05/19/24
IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 05/17/24
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 05/16/24
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 05/15/24
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/13/24
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesBusiness Wire • 05/13/24
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingBusiness Wire • 04/30/24
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingBusiness Wire • 04/22/24
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/19/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRBPRNewsWire • 04/04/24
ONGOING SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/04/24
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/03/24
Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 03/27/24
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Spruce Biosciences, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 03/22/24
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire • 03/21/24
